Get the latest industry news first when you subscribe to our daily newsletter.
We will never sell or share your information without your consent. See our privacy policy.
MedCity News
How Microsoft can transform healthcare delivery
Microsoft’s latest eBook offers a look at how technology can help organizations meet patients’ changing expectations and provide personalized care.
Shares0
It’s been just over one year since the Covid-19 public health crisis took hold in the US and the crisis has transformed how providers deliver and, as importantly, how patients access care. Healthcare organizations demonstrated amazing resilience, agility and innovation to focus attention on how best to engage diverse patient populations, according to their preferences and needs, as well as how best to deliver care.
Healthcare organizations quickly turned to the power of the cloud to expand critical care and improve care continuum, all while minimizing exposure to risk for staff and patients. Connecting with the right patients at the right time is critical and technology is vital to helping care providers respond to the evolving demands while providing ac
The shift to home care: Another new normal resulting from Covid-19
Covid-19 has highlighted the critical importance of increased communication and transparency between acute and post-acute providers, and the immediate need for more diverse acute and post-acute care options.
Shares0
The Covid-19 pandemic has magnified critical issues in the United States healthcare system, and has made significant, potentially long-lasting impacts on care transitions, referral patterns and care delivery across the acute and post-acute settings. In what may be our new normal at the post-acute level, many hospitals, patients and families continue to opt for in-home care over institutional care settings such as skilled nursing facilities (SNFs). This marked shift in care delivery preferences can be explained by several factors, whether it’s a patient or family’s fear surrounding SNF stays during the Covid-19 pandemic, families that worry they will be restricted from visiting a patient in a SNF, o
Forward, a concierge primary care startup, raised $225 million in funding. The San Francisco-based company plans to use the funds to expand to additional markets.
The positive data for the antibody drug from Vir Biotechnology and GlaxoSmithKline give a clearer picture of how and when these treatments could help. Last week, a different pivotal study testing the same drug in hospitalized patients yielded murkier results.